hospital covid-19 SOLIDARITY patient

Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments

Reading now: 206
www.sciencemag.org

Kai KupferschmidtScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.One of the world’s biggest trials of COVID-19 therapies released its long-awaited interim results yesterday—and they’re a letdown.

None of the four treatments in the Solidarity trial, which enrolled more than 11,000 patients in 400 hospitals around the globe, increased survival—not even the much-touted antiviral drug remdesivir.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA